PL355841A1 - Kompozycje farmaceutyczne - Google Patents

Kompozycje farmaceutyczne

Info

Publication number
PL355841A1
PL355841A1 PL00355841A PL35584100A PL355841A1 PL 355841 A1 PL355841 A1 PL 355841A1 PL 00355841 A PL00355841 A PL 00355841A PL 35584100 A PL35584100 A PL 35584100A PL 355841 A1 PL355841 A1 PL 355841A1
Authority
PL
Poland
Prior art keywords
pharmaceutical combinations
pharmaceutical
combinations
Prior art date
Application number
PL00355841A
Other languages
English (en)
Other versions
PL203430B1 (pl
Inventor
John Dixon
Robert Humphries
Gavin Jarvis
Ian Kirk
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PL355841A1 publication Critical patent/PL355841A1/pl
Publication of PL203430B1 publication Critical patent/PL203430B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL355841A 1999-12-01 2000-11-29 Zestaw leczniczy zawieraj acy antagonist e receptora P2T, zastosowanie antagonisty receptora P2T, preparat farmaceutyczny zawieraj acy antagonist e receptora P2T PL203430B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904377A SE9904377D0 (sv) 1999-12-01 1999-12-01 Pharmaceutical combinations
SE9904377-0 1999-12-01

Publications (2)

Publication Number Publication Date
PL355841A1 true PL355841A1 (pl) 2004-05-17
PL203430B1 PL203430B1 (pl) 2009-10-30

Family

ID=

Also Published As

Publication number Publication date
IS2841B (is) 2013-08-15
SE9904377D0 (sv) 1999-12-01
CA2391161C (en) 2010-10-05
RU2002117296A (ru) 2004-01-20
SK7502002A3 (en) 2003-02-04
AR033658A1 (es) 2004-01-07
HU230890B1 (hu) 2018-12-28
NZ530058A (en) 2005-04-29
EP1719526A3 (en) 2007-04-25
HUP0203585A2 (hu) 2003-03-28
EE200200271A (et) 2003-06-16
NO331215B1 (no) 2011-11-07
CY1105211T1 (el) 2010-03-03
ES2267591T3 (es) 2007-03-16
HK1047893A1 (en) 2003-03-14
MXPA02004871A (es) 2002-08-30
TWI251491B (en) 2006-03-21
DE60029340D1 (de) 2006-08-24
CO5271717A1 (es) 2003-04-30
DK1237559T3 (da) 2006-10-30
KR20020069201A (ko) 2002-08-29
DE60029340T2 (de) 2007-07-19
RU2242232C2 (ru) 2004-12-20
EP1719526A2 (en) 2006-11-08
EE05127B1 (et) 2009-02-16
MY128896A (en) 2007-02-28
US20030032618A1 (en) 2003-02-13
ATE332698T1 (de) 2006-08-15
CN1402639A (zh) 2003-03-12
NO20022606L (no) 2002-07-11
CA2391161A1 (en) 2001-06-07
PT1237559E (pt) 2006-10-31
AU781691B2 (en) 2005-06-09
AU1910901A (en) 2001-06-12
SI1237559T1 (sl) 2007-02-28
NZ518904A (en) 2004-02-27
JP2003515565A (ja) 2003-05-07
CZ300925B6 (cs) 2009-09-09
BR0016043A (pt) 2002-07-23
SK288707B6 (sk) 2019-10-02
EP1237559A1 (en) 2002-09-11
HUP0203585A3 (en) 2005-01-28
NO20022606D0 (no) 2002-05-31
IL149495A0 (en) 2004-03-28
WO2001039781A1 (en) 2001-06-07
EP1237559B1 (en) 2006-07-12
US20060270607A1 (en) 2006-11-30
ZA200203707B (en) 2003-10-29
CZ20021887A3 (cs) 2002-11-13
IS6398A (is) 2002-05-27
KR100785953B1 (ko) 2007-12-14

Similar Documents

Publication Publication Date Title
PL351387A1 (en) Pharmaceutical composition
IL142515A0 (en) Pharmaceutical kit
HUP0203585A3 (en) Pharmaceutical combinations
PL351686A1 (en) Novel pharmaceutical
AU142851S (en) Pharmaceutical kit
GB0025473D0 (en) Pharmaceutical combinations
EG23858A (en) Drug combination
IL145632A0 (en) Pharmaceutical compounds
EG23937A (en) Novel pharmaceutical
GB9916434D0 (en) Pharmaceutical compounds
HK1046140A1 (zh) 固體藥劑
GB9909041D0 (en) Novel pharmaceutical
GB9914255D0 (en) Pharmaceutical compounds
HRP20010951A2 (en) Pharmaceutical complex
GB9903784D0 (en) Pharmaceutical compounds
EG23946A (en) Novel pharmaceutical
GB2373499B (en) Pharmaceutical compounds
GB9923933D0 (en) Novel pharmaceutical
GB9923934D0 (en) Novel pharmaceutical
GB9926434D0 (en) Pharmaceutical
GB9926437D0 (en) Pharmaceutical
GB9902593D0 (en) Drug combinations
GB9904935D0 (en) Medicaments
GB9912196D0 (en) Novel pharmaceutical
GB9912197D0 (en) Novel pharmaceutical